LiquividaFranchise Cost, Revenue & Review 2026
Data from FDD filing + SBA 7(a) records
FranchiseVerdict summary · 2026
A Liquivida franchise requires a total initial investment of $98K – $1.0M, including a $75K franchise fee and an ongoing 6.0% royalty[2]. Per the 2025 FDD, average unit revenue was $1.1M[2]. Verdict grade: A. Run a live ROI scan →
Data last verified June 18, 2026 · figures per the 2025 FDD issuance
Overview
- Investment
- $98K – $1.0M
- 18th pct Healthcare
- Avg gross sales
- $1.1M
- 31st pct Healthcare
- Royalty
- 6.0%
- 14th pct Healthcare
- Units
- 15
- 35th pct Healthcare
- SBA default
- N/A
Quick verdict · Healthcare · color = vs category peers
Green = >15% above Healthcare avg · No shading = within ±15% · Red = >15% below avg · Source: FDD filings + SBA 7(a)
Data from public FDD filings and SBA records. Not financial advice. Methodology
Bottom line
- Total investment $98K – $1.0M including a $75K franchise fee, 6.0% ongoing royalty.
- Average unit revenue of $1.1M/year (median $926K).
- Verdict A (Top Quintile) with a risk score of 5/100.
- Bankruptcy history disclosed in the FDD. Review Item 4 for details before proceeding.
Item 1 · who you're contracting with
The Franchisor
- Legal entity
- LQV Franchising LLC
- Parent company
- LQV Management LLC
- Predecessor
- and Affiliates
- Prior franchisor entity
- Incorporated in
- FL
- HQ
- 4901 NW 17th Way, Suite 305, Fort Lauderdale, FL 33309
- Auditor
- Divine, Blalock, Martin & Sellari, LLC
- Audited financials
- Franchisor revenue
- $714K
- vs $899K prior year
Independent franchisee associations
- Franchise Advisory Council (FAC)
Franchisee-led councils or alliances disclosed in Item 20. Indicates operator voice.
Affiliated brands
- Liquivita
- is LQV Health
Other brands the franchisor or its parent operates (Item 1).
Overview
About
Liquivida franchisees operate IV therapy and wellness centers offering intravenous nutrient infusions, hydration therapies, and wellness drips to health-conscious consumers. Day-to-day operations include administering treatments (typically by licensed medical staff), managing client bookings, maintaining sterile equipment, handling inventory of IV solutions/nutrients, and building client relationships through repeat wellness visits.
- CEO
- Samael A. Tejada
- Headquarters
- FL
- Founded
- 2017
- FDD year
- 2025
- States available
- 4
FDD Item 7 · 2025 filing
Initial investment breakdown
| Cost component | Low | High |
|---|---|---|
| Initial franchise fee | $75K | $75K |
| Working capital (3–6 mo) | $25K | $225K |
| Equipment, build-out, other | $0 | $725K |
| Total initial investment | $98K | $1.0M |
Source: Liquivida 2025 FDD, Items 5 and 7[2]. “Equipment, build-out, other” is computed as total minus disclosed line items above.
Single-unit · estimated
Returns at a glance
Indicative numbers using FDD Item 7 / Item 19 inputs and category-benchmarked cost ratios. Full single-unit, 25-unit portfolio, and LBO models (with every input editable to stress-test your own scenario) live on the financials page.
Store EBITDA · annual
$180K
16.0% margin
Unlevered ROIC
26%
EBITDA / total invested capital
Payback
3.8 yrs
cash-on-cash, unlevered
Item 7 · what it costs to open + operate
The Vitals
- Total investment
- $98K – $1.0M
- Better than avg vs category
- Liquid capital req'd
- $25K – $225K
- Better than avg vs category
- Franchise fee
- $40K – $75K
- Below avg, review vs category
- Royalty
- 6.0%
- percentage_of_gross · typical 6–8%
- Ad fund
- $1,500
- Total fee load
- 6.0%
- vs 9–13% typical
Ongoing fees · Item 6
| Fee | Amount |
|---|---|
| Royalty | 6.0% of gross sales |
| Technology fee | $650 |
| Transfer fee | $10K |
| Renewal fee | $10K |
| Total fee load | 6.0% of rev |
A 6.0% total fee load is unusually lean. More of each revenue dollar stays with the franchisee.
Financial Performance
- Avg gross sales
- $1.1M
- Per unit, per year
- Median gross sales
- $926K
- Item 19 type
- gross_sales
- Sample size
- 12 units
- vs category median 12
- Range (low → high)
- $251K→$2.7M
- Cohort dispersion (min → max)
- Transparency
- 4 / 5
- vs category median 4 / 5 · typical
Compared against 201 Healthcare brands
vs Healthcare averages
How Liquivida Compares
Unit growth
Item 20 · unit dynamics
The Growth Chart
- Total units
- 15
- Opened
- 2
- Last reporting year
- Closed
- 0
- Turnover rate
- 0.0%
- Company-owned
- 3
- Corporate units in the system
- % franchised
- 80%
- vs corporate-owned
- Net growth (yr3)
- +20.0%
- Net unit change last year
- 3-yr CAGR
- +71.4%
- Compounded over last 3 years
3-year detail · Item 20
- Opened (3yr)
- 2
- Closed (3yr)
- 0
- Terminated (3yr)
- 0
- Non-renewed (3yr)
- 0
- Transfers (3yr)
- 2
- Reacquired (3yr)
- 0
- Franchisor bought back
Year-over-year franchised unit counts and net change. Source: FDD Item 20.
Item 20 · 9 states with active franchisees
The Territory Map
Derived from franchisee contact records. Shows states with at least one current operator. Not where the franchisor is registered to sell new units (that data is re-extracting in a future refresh).
States derived from franchisee contact records (FDD Item 20). Shows states with at least one current operator on file. Full state registration data (Item 12) will appear on a future FDD refresh.
SBA loan performance
Government records
SBA Loan Data
Aggregated from SBA 7(a) and 504 loan disclosures, public data unique to FranchiseVerdict.
- Total loans
- 30
- Loan volume
- N/A
- Amount data pending
- Median loan
- N/A
- Charge-off rate
- N/A
Historical SBA 7(a) lending data, not predictive of future performance. How SBA charge-off rates are calculated
- Repayment rate (PIF)
- N/A
- 5-yr charge-off
- N/A
- Loans approved 2021+
- Active lenders
- 0
- Defaults
- 0
Explore lender portfolios on Bank Reports or regional data on State Reports.
Risk analysis
FranchiseVerdict rating + FDD Items 3, 5, 6, 12, 17
Risk & Legal
Liquivida presents caution-level risk due to undisclosed profitability, franchisor going concern issues, litigation history, and a small, slowly-growing franchise system that raises sustainability questions.
Litigation (Item 3)
2 case reference(s): 0 pending, 3 settled.
Largest disclosed settlement: $510,000
Bankruptcy (Item 4)
Disclosed in last 7 years
Bankruptcy Court for the Southern District of Florida, Case No. 17-12326-JKO. On March 16, 2018, the Court entered an Order discharging his debts. There is no other bankruptcy required to be disclosed in this Item.
Audited financials (Item 21)
Yes · Divine, Blalock, Martin & Sellari, LLC
Franchisor revenue (Item 21)
Franchisor entity revenue (not unit-level)
Supplier relationship · Items 8 & 16
- Franchisor sells you products: No
- Must buy proprietary products: No
- Restricted to system-approved products: No
Score breakdown · what drove the 5 / 100 rating
- 01HIGHGoing Concern status is False, indicating potential financial instability at franchisor level
- 02HIGHSignificant litigation history with trademark enforcement and breach of contract allegations affecting franchisee confidence
- 03MEDNet income not disclosed despite $1.124M average revenue, making ROI projections impossible to validate
- 04MINORWide investment range ($97K-$1M+) suggests inconsistent unit economics or hidden costs not clearly explained
- 05MINOROnly 15 units with 20% YoY growth is modest for a wellness/IV therapy concept; small system increases franchisor risk
Severity inferred from the FDD text · not a regulatory classification
FDD Items 5, 6, 12, 17 · continued from Risk & Legal
Contract & Territory Detail
| Initial term | 10 years |
|---|---|
| Renewal term | 5 years |
| Allowed renewalsℹ | 2 |
| Territory type | Radius |
| Protected territory | Yes |
| Online sales rights | Restricted |
| Franchisor can compete | Yes |
| Hire a manager? | Allowed |
| Owner-operator | Required |
| Non-compete (years)ℹ | 2 years |
| Right of first refusalℹ | Yes |
| Termination notice | 30 days |
| Termination groundsℹ | 2 |
| Curable defaultsℹ | 3 |
| Mandatory arbitration | Yes |
| Jury trial waiver | Yes |
| Governing law | Florida |
| Litigation count | 2 |
View Item 3 litigation summary
2 case reference(s): 0 pending, 3 settled.
Items 10, 11
Training & Operations
- Classroom training
- 35 hrs
- On-the-job training
- 80 hrs
- Training location
- On-site and off-site
- Franchisor financing
- Not offered
- Item 10
- POS system
- Zenoti
- Operating tech stack
Items 5 & 11
Franchisor Support
Technology: Zenoti
Item 20 · call current owners
Franchisee Contacts
17 owners to call
Name · phone · city · state. Extracted from FDD Item 20
FDD download
Liquivida · FDD (2025) PDF
Frequently asked questions
Frequently Asked Questions
How much does it cost to open a Liquivida franchise?
The total investment to open a Liquivida franchise ranges from $98K – $1.0M, with an initial franchise fee of $75K. This includes real estate, equipment, inventory, and working capital as disclosed in their Franchise Disclosure Document (FDD).
What do Liquivida franchise owners earn?
According to Item 19 of the Liquivida FDD, the average gross sales per unit is $1.1M. The median is $926K. Note: this is gross revenue, not profit. Actual owner earnings vary based on location, operating costs, and management.
What is Liquivida's franchise failure rate?
SBA 7(a) loan charge-off data is not available for Liquivida (fewer than 10 loans on file). Charge-off rates are one way to gauge franchise risk, but not all franchise loans go through the SBA program. We recommend reviewing turnover and closure data in the FDD and speaking with current franchisees.
How many Liquivida franchise locations are there?
As of their most recent FDD filing, Liquivida has 15 total units in the United States, including 7 franchised units and 3 company-owned units. 2 new units were opened in the latest reporting year.
Is Liquivida a good franchise to buy?
FranchiseVerdict rates Liquivida as a A-grade franchise with a risk score of 5 out of 100, based on our analysis of investment costs, revenue data, SBA loan performance, and growth trends. Our rating is based solely on publicly available FDD and government data; we recommend speaking with current franchisees before making any investment decision. This is not investment advice.
Data sourced from public FDD filings and SBA 7(a) FOIA records. Not financial advice.
For franchisors
Are you the franchisor?
If you represent Liquivida, you can request corrections or provide updated information.
Claim this brandOther Healthcare franchises
Compare similar franchise opportunities in the Healthcare category
Data extracted from public FDD filings and SBA 7(a) loan disclosures (FOIA). This information is provided for research purposes only and does not constitute financial, legal, or investment advice. Verify all figures with the franchisor's current Franchise Disclosure Document before making any investment decision.